Naomi is a Partner in our Corporate Advisory group. She assists clients with general corporate advice and also has a background in commercial litigation.
Naomi’s corporate experience includes advising listed companies, unlisted companies, large and small proprietary companies, individuals, and trustees.
Naomi advises clients on capital raisings (including initial public offerings and secondary capital raisings), regulated mergers and takeovers, corporate acquisitions and divestments including due diligence, share acquisitions and scrip for scrip transactions, corporate restructuring, employee incentive schemes, regulatory requirements, private equity and venture capital investments and general corporate advice (including securities trading, director’s duties and corporate governance and compliance). She also has a background in commercial litigation.
Naomi was named as a finalist in Lawyers Weekly 30 Under 30 Awards for Mergers and Acquisitions Law 2017.
Advising on the $502 million acquisition of Viralytics Limited by Merck by scheme of arrangement.
Initial Public Offerings
Wagners Holding Company Limited, MSL Solutions Limited, Over the Wire Holdings Limited, OtherLevels Holdings Limited and Anatara Lifesciences Limited.
Secondary capital raisings
Viralytics Limited, Prescient Therapeutics Limited, Anatara Lifesciences Limited, Corporate Travel Management Limited, Factor Therapeutics Limited, OtherLevels Holdings Limited and Imugene Limited.
Over the Wire
Acquisitions of Faktortel, Sanity, Spiderbox and Telarus.
Technology One Limited
Acquisition of Jeff Roorda & Associates Pty Ltd and Desktop Mapping Systems Pty Ltd.